Millennium Management LLC Lowers Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Millennium Management LLC trimmed its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 21.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 90,037 shares of the company's stock after selling 24,946 shares during the period. Millennium Management LLC owned 0.20% of Avanos Medical worth $1,433,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in AVNS. T. Rowe Price Investment Management Inc. lifted its stake in shares of Avanos Medical by 27.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,011,312 shares of the company's stock worth $47,941,000 after buying an additional 644,267 shares in the last quarter. Brown Advisory Inc. lifted its stake in shares of Avanos Medical by 12.0% in the fourth quarter. Brown Advisory Inc. now owns 1,905,094 shares of the company's stock worth $30,329,000 after buying an additional 204,218 shares in the last quarter. D. E. Shaw & Co. Inc. lifted its stake in shares of Avanos Medical by 43.1% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 494,627 shares of the company's stock worth $7,874,000 after buying an additional 148,902 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Avanos Medical by 189.8% in the fourth quarter. JPMorgan Chase & Co. now owns 201,634 shares of the company's stock worth $3,210,000 after buying an additional 132,063 shares in the last quarter. Finally, Bridgeway Capital Management LLC lifted its stake in shares of Avanos Medical by 87.6% in the fourth quarter. Bridgeway Capital Management LLC now owns 273,251 shares of the company's stock worth $4,350,000 after buying an additional 127,591 shares in the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of Avanos Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, March 19th.

Avanos Medical Price Performance

Shares of NYSE:AVNS traded up $0.10 during midday trading on Friday, hitting $12.43. The company's stock had a trading volume of 242,851 shares, compared to its average volume of 368,338. Avanos Medical, Inc. has a 12-month low of $11.84 and a 12-month high of $25.36. The company has a market cap of $574.81 million, a P/E ratio of 36.56 and a beta of 1.13. The business's 50 day simple moving average is $12.62 and its 200 day simple moving average is $15.01. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.07. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The firm had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. During the same period last year, the business earned $0.22 earnings per share. Avanos Medical's revenue was up .8% compared to the same quarter last year. On average, analysts forecast that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.